Updated:
Medicxi Ventures
European life sciences venture firm led by Francesco De Rubertis, investing in biotech and digital health companies from Jersey and London.
Medicxi Ventures
Medicxi Ventures was founded as a spin-out from Index Ventures in 2016, led by Francesco De Rubertis, a life sciences veteran who had built Index's healthcare practice. The firm is headquartered in Jersey, which provides a tax-neutral regulatory base for its investment vehicles. The firm invests across early-stage and growth-stage life sciences companies, covering biotech therapeutics, diagnostics, and digital health. Medicxi typically leads or co-leads rounds and builds concentrated portfolios. Per public record, the firm raised multiple funds including a $300 million fund in 2019 and backed portfolio companies such as Mint Labs (per the company's announcement). Geographic focus is primarily Europe and the United States. Medicxi operates with a small investment team compared to larger venture firms. The Jersey-incorporated management entity reflects the firm's international LP base. No recent operational events of the last 24 months were confirmed through public sources. Medicxi's structural differentiator is its heritage as a specialist life sciences spin-out from a top-tier generalist venture firm, Index Ventures. The firm combines scientific depth with the operational experience of former pharma executives, enabling a hands-on approach to company building that is distinct from generic venture capital.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Jersey
City
Saint Helier
Corporate office
Saint Helier, Jersey
Principals
Francesco De Rubertis
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Medicxi Ventures?
Francesco De Rubertis is the lead partner at Medicxi, responsible for investment strategy and company building. The overall team is lean and partners have scientific or operational backgrounds in life sciences.
Does Medicxi Ventures operate as a single family office or a multi-family office?
Medicxi is structured as a venture capital firm, not a family office. It manages funds on behalf of institutional LPs and family offices, but the legal entity MEDICXI VENTURES MANAGEMENT (JERSEY) LIMITED is the management company.
What investment stages does Medicxi Ventures typically target?
Medicxi invests across stages from seed to growth in life sciences, with a focus on early-stage company creation and later-stage opportunities in biotech and digital health.
How does Medicxi source proprietary deal flow?
Proprietary deal flow is generated through deep scientific networks, relationships with academic institutions, and a strong reputation built by co-founding companies such as Mint Labs.
Which sectors does Medicxi Ventures explicitly avoid?
Medicxi focuses exclusively on life sciences and healthcare technology; it explicitly avoids sectors such as enterprise software, fintech, and consumer tech.
Does Medicxi Ventures participate in fund commitments or only direct deals?
Medicxi focuses on direct investments and company building, rather than fund-of-funds commitments. All capital is deployed directly into portfolio companies.
Where does the underlying wealth come from?
Medicxi manages institutional and family-office capital; the wealth origins of its LPs are not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: